New test can pinpoint which individuals with gonorrhea can be relieved with ciprofloxacin Kumar Jeetendra | August 7, 2020 A test made by UCLA researchers could pinpoint which individuals with gonorrhea will react successfully to the inexpensive oral antibiotic ciprofloxacin, which had formerly been sidelined over concerns the bacterium that causes the disease was becoming resistant to it. In study published in the peer-reviewed journal Clinical Infectious Diseases, a UCLA-led team found that of …
COVID-19 virus mutation that is ’10 times’ more irresistible recognized in Malaysia Kumar Jeetendra | August 17, 2020 KUALA LUMPUR: A mutation of this COVID-19 virus that is”10 times” more infectious was detected in Malaysia. The state’s Health Ministry director-general Noor Hisham Abdullah said the neighborhood needed to be careful, after a D614G mutation of the novel coronavirus was discovered. “It’s is found to be 10 times easier to infect different people and …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
Improving affectability of fluid biopsy utilizing ‘inexactly stacked’ identification layers Kumar Jeetendra | November 4, 2020 By detecting DNA fragments in body fluids like urine, some kinds of cancer may already be tracked in an early stage. But in order to capture them, detection sensitivity must be improved. Researchers at the University of Twente in The Netherlands (MESA+ Institute) use electrically charged polymers for this. Not only one layer of this, …
ATCC presents new product with launch of SARS-CoV-2 external control unit Kumar Jeetendra | December 4, 2020 The ready-to-run kit provides controls in the rapidly changing COVID-19 testing landscape as a workflow-optimized kit with complete genome coverage that is widely compatible with most commercial and laboratory-developed tests. Federal regulation requires that clinical laboratories assess the performance of their testing applications. This new ATCC kit is a practical, kitted solution clinical laboratories can …
Hematoxylin compounds can specifically kill CALR mutant cancer cells Kumar Jeetendra | December 11, 2020 Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR). Researchers of the research team of Robert Kralovics, Adjunct Principal Investigator in the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and team leader at the …
New information shows empowering results for patients with neuro-degenerative blinding eye illness Kumar Jeetendra | December 16, 2020 New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber Hereditary Optic Neuropathy (LHON. The disease is an inherited type of vision loss estimated to affect 1 in 30,000 to 50,000 individuals. LHON most often afflicts individuals with …
Skin may assist with foreseeing future heart issues Kumar Jeetendra | December 17, 2020 Our skin informs us when we have spent too much time in sunlight or when the dry air of winter has sucked away too much moisture. Now Jefferson researchers find that the skin may also foretell problems unrelated to the protective barrier. An international group of researchers headed by Jouni Uitto, MD, PhD, a Professor …
Another way to deal with distinguish genomic areas in our cerebrum that add to make us human Kumar Jeetendra | December 17, 2020 With just 1% gap, the human and chimpanzee protein-coding genomes are remarkably similar. Knowing the biological characteristics that make us human is a part of a fascinating and intensely debated line of study. The paper is printed in Science Advances. Gene expression, not gene arrangement To describe what sets human besides their ape relatives, researchers …
Hematoxylin compounds can specifically kill CALR freak disease cells Kumar Jeetendra | December 20, 2020 Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR). Scientists of the research group of Robert Kralovics, Adjunct Principal Investigator in the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and team leader at the …
